| 1. | The main outcome measure of the study was duration of survival
以生存时间做为研究的主要测定结果。 |
| 2. | Main outcome measures
主要结果测定 |
| 3. | Main outcome measure appropriate icd intervention terminating ventricular tachycardia or fibrillation
主要结果:对适当的icd介入治疗终止室速与室颤进行统计 |
| 4. | The main outcome measure was the deelopment of hepatitis e after receiing the full accine schedule
主要的评价结果来自于按要求接受完全程三次剂量的受试者的戊肝发病情况。 |
| 5. | Main outcome measure percentage of questions correct on a biostatistics / study design multiple - choice knowledge test
主要结果通过对生物统计学/研究结果知识多项选择题测试回答正确率来衡量。 |
| 6. | Main outcome measures recurrence rate , complication rate , hospital stay , nodal counts , blood loss , operating time
主要测量结果：疾病的复发率，并发症发病率，住院时间，淋巴结节计数，出血量，手术时间。 |
| 7. | Main outcome measures : surial free of major aderse cardiac eents defined as cardiac death , nonfatal mi , and / or symptom - drien reascularization
主要结果量度：无主要严重心脏意外（定义为心脏死亡、非致命的mi和/或症状驱动的血管形成术）的生存期。 |
| 8. | Main outcome measures the use of 21 classes of prescription medication was compared in the hormone therapy arms and placebo or nontreatment trial arms
主要结果测量方法：比较该试验激素替代治疗组（ 2个亚组） 、安慰剂组和非治疗组21类处方药的使用情况。 |
| 9. | Main outcome measure relatie sensitiity for cerical intraepithelial neoplasia of grade 2 or more at blindly reiewed histology , with atypical cells of undetermined significance or more seere cytology considered a positie result
主要观测指标：液基细胞学检出盲法观察组织学为2级或2级以上宫颈上皮内瘤相对灵敏度，不典型增生细胞或较严重细胞学异常认为阳性结果。 |
